Call for a Free Phone Consultation


Zantac Injury Lawsuits Scheduled to Proceed in 2022 and 2023

Posted on in Zantac

chicago drug defect lawyerFor years, Zantac was considered to be an effective treatment for heartburn, acid reflux, ulcers, and other gastrointestinal issues. However, Zantac and ranitidine, the generic equivalent of the drug, were taken off the market in 2020. This was done in response to studies that discovered that the drug could break down and form a substance that has been linked to multiple types of cancer. Because of the wide use of Zantac, millions of people may have been exposed to this substance, potentially causing them to experience serious illnesses. Numerous lawsuits have been filed against the manufacturers of Zantac and ranitidine, and in the coming months, these cases will begin being heard in courts.

What Is the Current Status of Zantac Litigation?

People who have suffered injuries or damages that were related to their use of Zantac may be able to pursue product liability lawsuits against the drug’s manufacturers. As of 2022, multiple state-level lawsuits have been filed, and over 2,000 federal cases are also being pursued. The federal lawsuits have been combined into multi-district litigation (MDL). A class action lawsuit is scheduled to begin in August 2022, and bellwether trials in the MDL cases are expected to commence in October 2022 and early 2023.

Lawsuits are being pursued against multiple companies that have manufactured and sold Zantac. GSK, formerly known as GlaxoSmithKline, originally launched Zantac in the 1980s, and Sanofi owned the rights to the over-the-counter version of the drug. Other companies have also released products containing ranitidine, including Pfizer, Johnson & Johnson, Haleon, and Boehringer Ingelheim. Through lawsuits, users of the drugs may be able to show that these companies knowingly allowed a dangerous drug to be sold to consumers.

Who Can Pursue a Zantac Lawsuit?

Users of Zantac may be able to pursue compensation if they have contracted cancer after taking the drug. Generally, a person must have taken Zantac or ranitidine at least once a week for a period of one year or more, and they must have been diagnosed with cancer within 20 years after they last used the drug. While Zantac has been associated with certain types of cancer, including stomach cancer, esophageal cancer, bladder cancer, liver cancer, and pancreatic cancer, all forms of cancer may be considered during a lawsuit. If a person can demonstrate that there is a link between their use of Zantac and their cancer, they may be able to receive compensation for their medical expenses, other financial damages such as loss of income, and pain and suffering.

Contact Our Chicago Zantac Injury Attorneys

If you or a member of your family have been diagnosed with any form of cancer after using Zantac or a generic equivalent, you may be entitled to compensation. Our knowledgeable and experienced Illinois defective drug injury lawyers are here to help. We will thoroughly review your case and help you understand all of your legal options. We will advise you on the best course of action and make sure you take the correct steps to pursue the compensation you deserve. To schedule a free consultation, call us today at 866-553-9812.


Back to Top